Study of Antimicrobial Resistance, Biofilm Formation, and Motility of Pseudomonas aeruginosa Derived from Urine Samples
暂无分享,去创建一个
G. Igrejas | M. Hébraud | P. Poeta | E. Costa | J. Pereira | L. Maltez | Ângela Martins | Telma de Sousa | Olimpia Alves | Â. Martins
[1] C. Cristea,et al. Analytical methods for the characterization and diagnosis of infection with Pseudomonas aeruginosa: A critical review. , 2022, Analytica chimica acta.
[2] R. Floyd,et al. Invasion and diversity in Pseudomonas aeruginosa urinary tract infections , 2022, Journal of medical microbiology.
[3] D. Débarre,et al. Substrate stiffness impacts early biofilm formation by modulating Pseudomonas aeruginosa twitching motility , 2022, bioRxiv.
[4] M. Saki,et al. Antibiotic resistance, biofilm production ability and genetic diversity of carbapenem-resistant Pseudomonas aeruginosa strains isolated from nosocomial infections in southwestern Iran , 2022, Molecular Biology Reports.
[5] G. Igrejas,et al. Genomic and Metabolic Characteristics of the Pathogenicity in Pseudomonas aeruginosa , 2021, International journal of molecular sciences.
[6] J. Pilewski,et al. Acidic Microenvironment Determines Antibiotic Susceptibility and Biofilm Formation of Pseudomonas aeruginosa , 2021, Frontiers in Microbiology.
[7] A. Onipede,et al. Antibiotic resistance pattern of Pseudomonas spp. from patients in a tertiary hospital in South-West Nigeria. , 2021, Germs.
[8] Madhu Dyavaiah,et al. Sesamin and sesamolin rescues Caenorhabditis elegans from Pseudomonas aeruginosa infection through the attenuation of quorum sensing regulated virulence factors. , 2021, Microbial pathogenesis.
[9] G. Nakazato,et al. Subinhibitory Concentrations of Biogenic Silver Nanoparticles Affect Motility and Biofilm Formation in Pseudomonas aeruginosa , 2021, Frontiers in Cellular and Infection Microbiology.
[10] J. Engel,et al. Mechanotaxis directs Pseudomonas aeruginosa twitching motility , 2021, Proceedings of the National Academy of Sciences.
[11] K. Chiam,et al. Dynamic swimming pattern of Pseudomonas aeruginosa near a vertical wall during initial attachment stages of biofilm formation , 2021, Scientific Reports.
[12] Minh Tam Tran Thi,et al. Pseudomonas aeruginosa Biofilms , 2020, International journal of molecular sciences.
[13] Thomas E. Wood,et al. From Welfare to Warfare: The Arbitration of Host-Microbiota Interplay by the Type VI Secretion System , 2020, Frontiers in Cellular and Infection Microbiology.
[14] D. Parai,et al. Naringin sensitizes the antibiofilm effect of ciprofloxacin and tetracycline against Pseudomonas aeruginosa biofilm. , 2020, International journal of medical microbiology : IJMM.
[15] C. Provot,et al. Clinical Impact of Antibiotics for the Treatment of Pseudomonas aeruginosa Biofilm Infections , 2020, Frontiers in Microbiology.
[16] P. Higgins,et al. Molecular surveillance of carbapenemase-producing Pseudomonas aeruginosa at three medical centres in Cologne, Germany , 2019, Antimicrobial Resistance and Infection Control.
[17] J. Dobnikar,et al. Effect of Topographical Steps on the Surface Motility of the Bacterium Pseudomonas aeruginosa. , 2019, ACS biomaterials science & engineering.
[18] M. Devereux,et al. Disarming Pseudomonas aeruginosa Virulence by the Inhibitory Action of 1,10-Phenanthroline-5,6-Dione-Based Compounds: Elastase B (LasB) as a Chemotherapeutic Target , 2019, Front. Microbiol..
[19] Shaomin Yan,et al. Can Biofilm Be Reversed Through Quorum Sensing in Pseudomonas aeruginosa? , 2019, Front. Microbiol..
[20] S. Shoja,et al. Integron types, antimicrobial resistance genes, virulence gene profile, alginate production and biofilm formation in Iranian cystic fibrosis Pseudomonas aeruginosa isolates. , 2018, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.
[21] M. Salih,et al. Molecular characterization of Pseudomonas aeruginosa isolates from Sudanese patients: A cross-sectional study , 2018, F1000Research.
[22] Florian P Maurer,et al. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations , 2018, PloS one.
[23] L. R. Alves,et al. Biofilm production by clinical isolates of Pseudomonas aeruginosa and structural changes in LasR protein of isolates non biofilm-producing , 2018, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[24] Shuhong Sun,et al. Molecular Characterization of Antimicrobial Resistance in Escherichia coli from Rabbit Farms in Tai'an, China , 2018, BioMed research international.
[25] A. L. Santos,et al. Heterogeneous production of proteases from Brazilian clinical isolates of Pseudomonas aeruginosa. , 2017, Enfermedades infecciosas y microbiologia clinica.
[26] L. MacNeil,et al. Pseudomonas aeruginosa type IV minor pilins and PilY1 regulate virulence by modulating FimS-AlgR activity , 2017, bioRxiv.
[27] J. Fothergill,et al. The contribution of Pseudomonas aeruginosa virulence factors and host factors in the establishment of urinary tract infections. , 2017, FEMS microbiology letters.
[28] A. Mérieau,et al. The Type VI Secretion System: A Dynamic System for Bacterial Communication? , 2017, Front. Microbiol..
[29] Suresh Neethirajan,et al. Electroceutical Approach for Impairing the Motility of Pathogenic Bacterium Using a Microfluidic Platform , 2017, Micromachines.
[30] K. Ko,et al. Microbiological features and clinical impact of the type VI secretion system (T6SS) in Acinetobacter baumannii isolates causing bacteremia , 2017, Virulence.
[31] C. Torres,et al. Characterisation of carbapenem-resistance mechanisms in clinical Pseudomonas aeruginosa isolates recovered in a Spanish hospital. , 2017 .
[32] M. Castanheira,et al. Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States , 2017, Antimicrobial Agents and Chemotherapy.
[33] F. Fallah,et al. Molecular detection of virulence genes in Pseudomonas aeruginosa isolated from children with Cystic Fibrosis and burn wounds in Iran. , 2016, Microbial pathogenesis.
[34] M. Yousefi,et al. Presence of exoY, exoS, exoU and exoT genes, antibiotic resistance and biofilm production among Pseudomonas aeruginosa isolates in Northwest Iran , 2016, GMS hygiene and infection control.
[35] M. Ahangarzadeh Rezaee,et al. Emergence of colistin resistant Pseudomonas aeruginosa at Tabriz hospitals, Iran , 2016, Iranian journal of microbiology.
[36] C. Kulah,et al. Investigation of OprD Porin Protein Levels in Carbapenem-Resistant Pseudomonas aeruginosa Isolates , 2015, Jundishapur journal of microbiology.
[37] B. Kazmierczak,et al. Cross-regulation of Pseudomonas motility systems: the intimate relationship between flagella, pili and virulence. , 2015, Current opinion in microbiology.
[38] L. Burrows,et al. Biogenesis of Pseudomonas aeruginosa type IV pili and regulation of their function. , 2015, Environmental microbiology.
[39] F. Klawonn,et al. The LasB Elastase of Pseudomonas aeruginosa Acts in Concert with Alkaline Protease AprA To Prevent Flagellin-Mediated Immune Recognition , 2015, Infection and Immunity.
[40] M. Nour,et al. Genetic Identification of Pseudomonas aeruginosa Virulence Genes among Different Isolates , 2015 .
[41] H. Stone,et al. Type IV pili mechanochemically regulate virulence factors in Pseudomonas aeruginosa , 2015, Proceedings of the National Academy of Sciences.
[42] S. McClean,et al. Bacterial Adaptation during Chronic Respiratory Infections , 2015, Pathogens.
[43] T. Sawa,et al. Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review , 2014, Critical Care.
[44] M. Taherikalani,et al. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients. , 2014, Burns : journal of the International Society for Burn Injuries.
[45] S. Chhibber,et al. Molecular detection of virulence genes as markers in Pseudomonas aeruginosa isolated from urinary tract infections. , 2014, International journal of molecular epidemiology and genetics.
[46] H. Momtaz,et al. Virulence Gene Profiles of Multidrug-Resistant Pseudomonas aeruginosa Isolated From Iranian Hospital Infections , 2014, Iranian Red Crescent medical journal.
[47] R. Garg,et al. Comparative Study of Biofilm Formation in Pseudomonas aeruginosa Isolates from Patients of Lower Respiratory Tract Infection. , 2014, Journal of clinical and diagnostic research : JCDR.
[48] Vincent T. Lee,et al. Catheter-Associated Urinary Tract Infection by Pseudomonas aeruginosa Is Mediated by Exopolysaccharide-Independent Biofilms , 2014, Infection and Immunity.
[49] A. Pitondo-Silva,et al. Pathogenic potential and genetic diversity of environmental and clinical isolates of Pseudomonas aeruginosa , 2014, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[50] R. Geffers,et al. Human Host Defense Peptide LL-37 Stimulates Virulence Factor Production and Adaptive Resistance in Pseudomonas aeruginosa , 2013, PloS one.
[51] S. Janković,et al. Nosocomial urinary tract infections caused by Pseudomonas aeruginosa and Acinetobacter species: sensitivity to antibiotics and risk factors. , 2013, American journal of infection control.
[52] S. Abidi,et al. Drug resistance profile and biofilm forming potential of Pseudomonas aeruginosa isolated from contact lenses in Karachi-Pakistan , 2013, BMC Ophthalmology.
[53] B. Cournoyer,et al. Lagooning of wastewaters favors dissemination of clinically relevant Pseudomonas aeruginosa. , 2013, Research in microbiology.
[54] Chander Anil,et al. ANTIMICROBIAL SUSCEPTIBILITY PATTERNS OF PSEUDOMONAS AERUGINOSA CLINICAL ISOLATES AT A TERTIARY CARE HOSPITAL IN KATHMANDU, NEPAL , 2013 .
[55] U. Sekar,et al. bla(IMP) and bla(VIM) mediated carbapenem resistance in Pseudomonas and Acinetobacter species in India. , 2012, Journal of infection in developing countries.
[56] L. Burrows. Pseudomonas aeruginosa twitching motility: type IV pili in action. , 2012, Annual review of microbiology.
[57] T. Mah. Biofilm-specific antibiotic resistance. , 2012, Future microbiology.
[58] A. Gales,et al. Metallo-β-lactamase-production in meropenem-susceptible Pseudomonas aeruginosa isolates: risk for silent spread. , 2012, Memorias do Instituto Oswaldo Cruz.
[59] S. Hong,et al. Multiplex PCR for Rapid Detection of Genes Encoding Class A Carbapenemases , 2012, Annals of laboratory medicine.
[60] R. Alaghehbandan,et al. KPC-producer gram negative bacteria among burned infants in Motahari Hospital, Tehran: first report from Iran. , 2012, Annals of burns and fire disasters.
[61] B. Kazmierczak,et al. Type IV Pilus Assembly in Pseudomonas aeruginosa over a Broad Range of Cyclic di-GMP Concentrations , 2012, Journal of bacteriology.
[62] W. Hol,et al. The type II secretion system: biogenesis, molecular architecture and mechanism , 2012, Nature Reviews Microbiology.
[63] Karina B. Xavier,et al. The Multiple Signaling Systems Regulating Virulence in Pseudomonas aeruginosa , 2012, Microbiology and Molecular Reviews.
[64] D. Livermore,et al. The emerging NDM carbapenemases. , 2011, Trends in microbiology.
[65] T. Mah,et al. Pseudomonas aeruginosa tssC1 Links Type VI Secretion and Biofilm-Specific Antibiotic Resistance , 2011, Journal of bacteriology.
[66] N. Tufenkji,et al. The Swarming Motility of Pseudomonas aeruginosa Is Blocked by Cranberry Proanthocyanidins and Other Tannin-Containing Materials , 2011, Applied and Environmental Microbiology.
[67] G. O’Toole. Microtiter dish biofilm formation assay. , 2011, Journal of visualized experiments : JoVE.
[68] S. Chevalier,et al. Full Virulence of Pseudomonas aeruginosa Requires OprF , 2010, Infection and Immunity.
[69] M. Burattini,et al. Metallo‐beta‐lactamases among imipenem‐resistant Pseudomonas aeruginosa in a brazilian university hospital , 2010, Clinics.
[70] Mathias Müsken,et al. A 96-well-plate–based optical method for the quantitative and qualitative evaluation of Pseudomonas aeruginosa biofilm formation and its application to susceptibility testing , 2010, Nature Protocols.
[71] B. Markova,et al. Prevalence of Virulence Genes Among Bulgarian Nosocomial and Cystic Fibrosis Isolates of Pseudomonas Aeruginosa , 2010, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].
[72] T. Murray,et al. Swarming motility, secretion of type 3 effectors and biofilm formation phenotypes exhibited within a large cohort of Pseudomonas aeruginosa clinical isolates. , 2010, Journal of medical microbiology.
[73] D. Berrar,et al. Pseudomonas aeruginosa Cystic Fibrosis isolates of similar RAPD genotype exhibit diversity in biofilm forming ability in vitro , 2010, BMC Microbiology.
[74] L. Burrows,et al. Novel Proteins That Modulate Type IV Pilus Retraction Dynamics in Pseudomonas aeruginosa , 2008, Journal of bacteriology.
[75] Somsuvra B. Ghatak,et al. Antibiotic susceptibility patterns of Pseudomonas aeruginosa at a tertiary care hospital in Gujarat, India , 2008, Indian journal of pharmacology.
[76] Michelle D. Brazas,et al. Swarming of Pseudomonas aeruginosa Is a Complex Adaptation Leading to Increased Production of Virulence Factors and Antibiotic Resistance , 2008, Journal of bacteriology.
[77] Julien Tremblay,et al. Self-produced extracellular stimuli modulate the Pseudomonas aeruginosa swarming motility behaviour. , 2007, Environmental microbiology.
[78] F. Baquero,et al. Antibiotics as intermicrobial signaling agents instead of weapons , 2006, Proceedings of the National Academy of Sciences.
[79] N. Woodford,et al. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. , 2006, The Journal of antimicrobial chemotherapy.
[80] V. Venturi. Regulation of quorum sensing in Pseudomonas. , 2006, FEMS microbiology reviews.
[81] T. Sawa,et al. Targeting mechanisms of Pseudomonas aeruginosa pathogenesis. , 2006, Medecine et maladies infectieuses.
[82] S. Molin,et al. Heterogeneity of Biofilms Formed by Nonmucoid Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis , 2005, Journal of Clinical Microbiology.
[83] M. Nucci,et al. Risk Factors for Acquisition of Multidrug-Resistant Pseudomonas aeruginosa Producing SPM Metallo-β-Lactamase , 2005, Antimicrobial Agents and Chemotherapy.
[84] G. O’Toole,et al. Evidence for Two Flagellar Stators and Their Role in the Motility of Pseudomonas aeruginosa , 2005, Journal of bacteriology.
[85] J. Schaber,et al. Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa. , 2004, Journal of medical microbiology.
[86] M. Parsek,et al. Identification of psl, a Locus Encoding a Potential Exopolysaccharide That Is Essential for Pseudomonas aeruginosa PAO1 Biofilm Formation , 2004, Journal of bacteriology.
[87] S. Rice,et al. Pseudomonas aeruginosa with lasI quorum-sensing deficiency during corneal infection. , 2004, Investigative ophthalmology & visual science.
[88] J. Emerson,et al. Clinically Feasible Biofilm Susceptibility Assay for Isolates of Pseudomonas aeruginosa from Patients with Cystic Fibrosis , 2004, Journal of Clinical Microbiology.
[89] Gianfranco Amicosante,et al. Multiple CTX-M-Type Extended-Spectrum β-Lactamases in Nosocomial Isolates of Enterobacteriaceae from a Hospital in Northern Italy , 2003, Journal of Clinical Microbiology.
[90] J. Wiener-Kronish,et al. Single-Nucleotide-Polymorphism Mapping of the Pseudomonas aeruginosa Type III Secretion Toxins for Development of a Diagnostic Multiplex PCR System , 2003, Journal of Clinical Microbiology.
[91] P. Nordmann,et al. Ambler Class A Extended-Spectrum β-Lactamases in Pseudomonas aeruginosa: Novel Developments and Clinical Impact , 2003, Antimicrobial Agents and Chemotherapy.
[92] F. Lépine,et al. rhlA is required for the production of a novel biosurfactant promoting swarming motility in Pseudomonas aeruginosa: 3-(3-hydroxyalkanoyloxy)alkanoic acids (HAAs), the precursors of rhamnolipids. , 2003, Microbiology.
[93] P. Gastmeier. Nosocomial urinary tract infections: many unresolved questions. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[94] A. Hauser,et al. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. , 2001, Microbiology.
[95] E. Bouza,et al. A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[96] A. Oliver,et al. Characterization of Clinical Isolates ofKlebsiella pneumoniae from 19 Laboratories Using the National Committee for Clinical Laboratory Standards Extended-Spectrum β-Lactamase Detection Methods , 2001, Journal of Clinical Microbiology.
[97] C. van Delden,et al. Swarming of Pseudomonas aeruginosa Is Dependent on Cell-to-Cell Signaling and Requires Flagella and Pili , 2000, Journal of bacteriology.
[98] S. Lory,et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen , 2000, Nature.
[99] J W Warren,et al. Catheter-associated urinary tract infections. , 1997, International journal of antimicrobial agents.
[100] B. Iglewski,et al. Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes , 1997, Journal of bacteriology.
[101] P. Seed,et al. Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa , 1997, Journal of bacteriology.
[102] J. Mattick,et al. Identification of a gene, pilV, required for type 4 fimbrial biogenesis in Pseudomonas aeruginosa, whose product possesses a pre‐pilin‐like leader sequence , 1995, Molecular microbiology.
[103] G. Paul,et al. Nucleotide sequences of the genes coding for the TEM-like beta-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2). , 1994, FEMS microbiology letters.
[104] J. Vliegenthart,et al. Nomenclature of aminoglycoside resistance genes: a comment , 1993, Antimicrobial Agents and Chemotherapy.
[105] S. Lory,et al. Products of three accessory genes, pilB, pilC, and pilD, are required for biogenesis of Pseudomonas aeruginosa pili , 1990, Journal of bacteriology.
[106] B. Iglewski,et al. Molecular characterization and nucleotide sequence of the Pseudomonas aeruginosa elastase structural gene , 1988, Journal of bacteriology.
[107] Iosr Journals,et al. Susceptibility Pattern of Bacterial Isolates from Catheterised Patients in a Referral Hospital , 2014 .
[108] S. Minagawa,et al. Type IV pilus protein PilA of Pseudomonas aeruginosa modulates calcium signaling through binding the calcium-modulating cyclophilin ligand , 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[109] Tetsuro Kato,et al. Clinical characteristics and risk factors for mortality in patients with bacteremia caused by Pseudomonas aeruginosa. , 2012, Internal medicine.
[110] Sudhir Aggarwal,et al. Urinary tract infections caused by Pseudomonas aeruginosa: a minireview. , 2009, Journal of infection and public health.
[111] K. Wolska,et al. Genetic features of clinical Pseudomonas aeruginosa strains. , 2009, Polish journal of microbiology.
[112] A. Dashti,et al. Heat Treatment of Bacteria: A Simple Method of DNA Extraction for Molecular Techniques , 2009 .